Bioinformatics and In Vivo Experiments Identify Hmgcs2 as a Key Gene Linking Fatty Acid Metabolism and Lactylation in Acute Kidney Injury Associated with Sepsis
Abstract Background Sepsis-associated acute kidney injury (S-AKI) is a severe critical care complication with high morbidity and mortality, involving inflammatory dysregulation, metabolic reprogramming, and immune dysfunction. However, the molecular link between fatty acid metabolism disorders and lactylation in S-AKI remains unclear, and systematic screening with functional validation is lacking. Methods Based on mouse kidney transcriptome datasets, we performed DEGs analysis, GSEA, GO/KEGG enrichment, and LASSO regression to screen key candidates. Intersection analyses with fatty acid metabolism and lactylation-related gene sets were conducted to identify core targets. Diagnostic value was evaluated by ROC curves, immune infiltration by CIBERSORT, and in vivo validation in a CLP-induced S-AKI mouse model. Results A total of 359 DEGs were identified, with GSEA revealing significant enrichment of inflammation and metabolism pathways. LASSO narrowed candidates to 16 feature genes. Four-set Venn intersection identified Hmgcs2 as the only core target intersecting both fatty acid metabolism and lactylation-related gene sets. ROC analysis confirmed good diagnostic efficacy (AUC > 0.7). Immune infiltration showed increased M0 macrophages and neutrophils in S-AKI, significantly correlated with Hmgcs2 expression. In vivo experiments confirmed significant upregulation of Hmgcs2 mRNA and protein in renal tissues after CLP. Conclusion This study, integrating bioinformatics, machine learning, and in vivo experiments, incorporates fatty acid metabolism and lactylation into a unified screening framework and identifies Hmgcs2 as a key network node bridging these two dimensions. As the rate-limiting enzyme of ketogenesis, Hmgcs2 may regulate renal energy homeostasis through FAO and potentially influence lactylation-related epigenetic networks by reshaping the metabolic microenvironment, exerting renoprotective effects in S-AKI. Hmgcs2 shows promise as a diagnostic biomarker and therapeutic target for S-AKI.
Authors
- Xuan Shang
- Na Xia
- Yawen Wu (ORCID: https://orcid.org/0009-0009-9494-3555)
- Hongmei Zhang
- Jianying Bai
- Jinzhi Song
- Gehui Xiao
- Xueqin Li
Institutions
- Shanxi Medical University (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11306189/v1
- Primary Topic
- Acute Kidney Injury Research
- Type
- preprint